Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon P Langdon

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Cellular Signalling|December 24, 2022
Variation in IL6ST cytokine family function and the potential of IL6 trans-signalling in ERα positive breast cancer cellsDuniya Mosly, Kenneth MacLeod, Nicholas Moir, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2007
Progressive loss of estrogen receptor alpha cofactor recruitment in endocrine resistanceCatherine Naughton, Kenneth MacLeod, Barbara Kuske, et al.
Cellular Signalling|October 15, 2011
Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibitionAlexey Goltsov, Dana Faratian, Simon P Langdon, et al.
Cellular Signalling|October 19, 2010
Compensatory effects in the PI3K/PTEN/AKT signaling network following receptor tyrosine kinase inhibitionAlexey Goltsov, Dana Faratian, Simon P Langdon, et al.
Oxidative Medicine and Cellular Longevity|January 16, 2016
NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted ImmunotherapiesHilal S Khalil, Simon P Langdon, Ibrahim H Kankia, et al.
Scientific Reports|June 9, 2015
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model systemAntonis Koussounadis, Simon P Langdon, In Hwa Um, et al.
Molecular Cancer Research : MCR|September 10, 2009
Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer: implications for pertuzumab sensitivityYoko Nagumo, Dana Faratian, Peter Mullen, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2010
Cancer systems biologyDana Faratian, James L Bown, V Anne Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Antisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancerPeter Mullen, Fiona McPhillips, Kenneth MacLeod, et al.
Journal of Biotechnology|December 3, 2014
Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cellsHilal S Khalil, Alexey Goltsov, Simon P Langdon, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Cellular Signalling|December 24, 2022
Variation in IL6ST cytokine family function and the potential of IL6 trans-signalling in ERα positive breast cancer cellsDuniya Mosly, Kenneth MacLeod, Nicholas Moir, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2007
Progressive loss of estrogen receptor alpha cofactor recruitment in endocrine resistanceCatherine Naughton, Kenneth MacLeod, Barbara Kuske, et al.
Cellular Signalling|October 15, 2011
Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibitionAlexey Goltsov, Dana Faratian, Simon P Langdon, et al.
Cellular Signalling|October 19, 2010
Compensatory effects in the PI3K/PTEN/AKT signaling network following receptor tyrosine kinase inhibitionAlexey Goltsov, Dana Faratian, Simon P Langdon, et al.
Oxidative Medicine and Cellular Longevity|January 16, 2016
NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted ImmunotherapiesHilal S Khalil, Simon P Langdon, Ibrahim H Kankia, et al.
Scientific Reports|June 9, 2015
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model systemAntonis Koussounadis, Simon P Langdon, In Hwa Um, et al.
Molecular Cancer Research : MCR|September 10, 2009
Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer: implications for pertuzumab sensitivityYoko Nagumo, Dana Faratian, Peter Mullen, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2010
Cancer systems biologyDana Faratian, James L Bown, V Anne Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Antisense oligonucleotide targeting of Raf-1: importance of raf-1 mRNA expression levels and raf-1-dependent signaling in determining growth response in ovarian cancerPeter Mullen, Fiona McPhillips, Kenneth MacLeod, et al.
Journal of Biotechnology|December 3, 2014
Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cellsHilal S Khalil, Alexey Goltsov, Simon P Langdon, et al.
Pageof 9